Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
24.13
+0.12 (0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed

Xencor Revenue

Xencor had revenue of $10.71M in the quarter ending September 30, 2024, a decrease of -81.90%. This brings the company's revenue in the last twelve months to $85.16M, down -41.37% year-over-year. In the year 2023, Xencor had annual revenue of $168.34M with 2.28% growth.

Revenue (ttm)
$85.16M
Revenue Growth
-41.37%
P/S Ratio
17.55
Revenue / Employee
$304,157
Employees
280
Market Cap
1.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023168.34M3.76M2.28%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.59B
Astrana Health 1.72B
Integra LifeSciences Holdings 1.56B
National HealthCare 1.22B
GoodRx Holdings 790.39M
10x Genomics 629.74M
Certara 372.80M
Dynavax Technologies 260.81M
Revenue Rankings